Report Library
All Reports
JP Morgan 2019 - Day 3
January 09, 2019
The 37th annual JP Morgan Healthcare Conference is being held in San Francisco, CA from January 7-10, 2019. A list of events and
catalysts that were announced or updated at the conference today is included in this report.
Highlights from today’s company presentations are included for:
Large Cap
For our disclosures, please read the Biomedtracker Research Standards.
Highlights from today’s company presentations are included for:
Large Cap
- AbbVie (ABBV)
- CSL Ltd (CSL:AU)
- Ipsen SA (IPSEY)
- Acadia Pharmaceuticals (ACAD)
- Amarin Corporation (AMRN)
- Galapagos NV (GLPG)
- Halozyme Therapeutics (HALO)
- Intercept Pharmaceutical (ICPT)
- Lee's Pharmaceutical Holdings (0950.HK)
- Morphosys AG (MOR)
- Novocure (NVCR)
- Acorda Therapeutics (ACOR)
- AMAG Pharmaceuticals (AMAG)
- Five Prime Therapeutics (FPRX)
- Idera Pharmaceuticals (IDRA)
- ImmunoGen (IMGN)
- Molecular Partners AG (MOLN.SW)
- Replimune (REPL)
- Sangamo Therapeutics (SGMO)
- Sienna Biopharmaceuticals (SNNA)
- Solid Biosciences (SLDB)
- Supernus Pharmaceuticals (SUPN)
- Tricida (TCDA)
For our disclosures, please read the Biomedtracker Research Standards.
| Disease Group Covered: |
Allergy
Autoimmune/immunology Cardiovascular Dermatology Endocrine ENT/Dental Gastroenterology (Non Inflammatory Bowel Disease) Hematology Infectious Disease Metabolic Neurology Not Specified Obstetrics/Gynecology Oncology Ophthalmology Orthopedics Psychiatry Renal Respiratory Rheumatology (Non Autoimmune) Urology |
Additional Resources: